Intellia Therapeutics, Inc.
← Back to NTLA Overview

Intellia Therapeutics, Inc. (NTLA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.54

Financial Fundamentals

NTLAQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-06-30-90.33
2014-12-31-2.23
2015-03-31-89.29
2015-06-30-32.10
2015-09-30-32.33
2015-12-31-18.61
2016-03-31-28.31
2016-06-30-14.79
2016-09-30-19.52
2016-12-31-10.71
2017-03-31-9.68
2017-06-30-8.96
2017-09-30-14.24
2017-12-31-7.85
2018-03-31-10.38
2018-06-30-13.19
2018-09-30-12.89
2018-12-31-7.91
2019-03-31-8.83
2019-06-30-7.33
2019-09-30-6.86
2019-12-31-6.40
2020-03-31-4.85
2020-06-30-8.66
2020-09-30-10.49
2020-12-31-19.76
2021-03-31-29.17
2021-06-30-40.10
2021-09-30-34.50
2021-12-31-27.08
2022-03-31-9.25
2022-06-30-9.75
2022-09-30-9.40
2022-12-31-6.25
2023-03-31-7.93
2023-06-30-7.27
2023-09-30-5.73
2023-12-31-5.22
2024-03-31-6.05
2024-06-30-3.71
2024-09-30-3.82
2024-12-31-2.30
2025-03-31-1.61
2025-06-30-2.40
2025-09-30-4.70
2025-12-31-2.54

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.